Major Depressive Disorder (MDD) is a chronic disorder for many people. It is now a principle of chronic disease management that we “treat to target”, and we can’t treat what we don’t measure. It is important to have screening and measurement tools that allow us to sharpen the focus so we are clear what the therapeutic targets are. They also inform our treatments, enhancing the precision, the consistency and the appropriateness of the treatments we select.

The THINC-it® tool is the first ever tool that has been developed to screen for the presence of cognitive deficits in adults who have MDD.

Patients and clinicians alike are underwhelmed by current outcomes in depression. There is strong motivation to improve them.

Cognitive deficits in depression are not just common, they are a principal determinant of health outcomes: a treatable dimension of illness that should inform treatment selection.

The aim of the study was to validate the tool. We showed that THINC-it® can detect cognitive deficits in adults with major depression: almost 80% of MDD patients are at least half a standard deviation below the matched controls on their overall cognitive function.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.